2022 & 2024 Drug Resistance Gordon Research Conference and Seminar
2022 & 2024 Drug Resistance Gordon Research Conference and Seminar
批准号:
10468465
负责人:
Lizbeth K. Hedstrom
金额:
$0.55万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-06-15 至 2023-05-31
关键词:
AddressAgricultureAnti-Bacterial AgentsAntifungal AgentsAntineoplastic AgentsAntiparasitic AgentsAntiviral AgentsAreaAwardCollaborationsCommunicable DiseasesCommunitiesCountryDisciplineDiseaseDrug DesignDrug resistanceEmpathyEnvironmentFaceFoundationsGeographyGoalsGovernmentHerbicidesHourIndustryInsectaInsecticidesInstitutionInvestigationLife ExpectancyMalignant NeoplasmsMethodologyMindModelingModernizationOrganismPharmaceutical PreparationsPhysiciansPostdoctoral FellowRequest for ProposalsResearchResearch PersonnelResistanceResistance developmentRisk-TakingScienceScientistSystemTechniquesTimeTravelWomanWorkcareercombatcoronavirus diseasedrug resistant pathogenexperiencegraduate studentmeetingsmicrobiomenovelnovel strategiespesticide resistancepostersprogramsrecruitresistance mechanismresponsesuccesssymposium
中文摘要
项目总结
英文摘要
PROJECT SUMMARY
The prosperity of the modern world is threatened by the relentless emergence of drug-resistant
pathogens, pesticide-resistant insects and herbicide-resistant weeds. New investigational
cancer drugs increase life expectancy, but inevitably fail when resistance develops. Although
the threat of resistance is shared, the fields of infectious disease, cancer and agriculture have
largely responded independently. Work on resistance is typically siloed in organism-specific
conferences- even within infectious diseases, scientists working on antibacterials, antifungals,
antiparasitics, and antivirals rarely communicate. The 2022 Gordon Research Conference on
Drug Resistance uniquely bring together scientists studying infectious disease, anticancer
agents, insecticides and herbicides to discuss the common threat of resistance. We are
requesting partial support for these conferences to defray registration and travel expenses for
speakers and select attendees, specifically early career investigators, post docs and graduate
students. Our goal is to mount a program of 36 speakers, 8-12 chosen from poster abstracts,
with 9 sessions describing recent advances in the field. The opening/closing keynote sessions
will be (1) Challenges and Opportunities of Understanding Resistance Mechanisms in
Agriculture and (9) Emerging Strategies to Combat Resistance. Other sessions will include (2)
Mechanisms of Resistance, (3) Systems and Modeling Strategies to Address Resistance, (4)
Combating Resistance with Novel Targets, (5) Durable Drug Design, (6) Eco-Evolutionary
Strategies to Address Resistance, (7) Threats and Responses and (8) The Microbiome and
Resistance. The speakers and discussion leaders will be recruited from across the fields of
infectious disease, cancer and agriculture, drawn from academics, government organizations,
foundations and industry (both small and large). We will also aggressively recruit a mix of
attendees from many different countries and institutions, with diverse expertise, new
perspectives and open minds because the success of this conference relies on abroad
representation of disciplines, varying seniority, and wide geographic and cultural perspectives.
All attendees will have the option of presenting their work during afternoon poster sessions and
junior investigators will also have the opportunity to attend an associated Gordon Research
Seminar. The meeting will also include a GRC Power hour to discuss and address the
challenges women face in the field.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ubiquitin-independent targeted protein degradation
-
批准号:10678852
-
项目类别:
-
资助金额:$69.16万
-
财政年份:2020
-
负责人:Lizbeth K. Hedstrom
-
依托单位:
Ubiquitin-independent targeted protein degradation
-
批准号:10240677
-
项目类别:
-
资助金额:$69.38万
-
财政年份:2020
-
负责人:Lizbeth K. Hedstrom
-
依托单位:
Ubiquitin-independent targeted protein degradation
-
批准号:10797292
-
项目类别:
-
资助金额:$11.7万
-
财政年份:2020
-
负责人:Lizbeth K. Hedstrom
-
依托单位:
Ubiquitin-independent targeted protein degradation
-
批准号:10810215
-
项目类别:
-
资助金额:$1.2万
-
财政年份:2020
-
负责人:Lizbeth K. Hedstrom
-
依托单位:
Ubiquitin-independent targeted protein degradation
-
批准号:10021774
-
项目类别:
-
资助金额:$74.18万
-
财政年份:2020
-
负责人:Lizbeth K. Hedstrom
-
依托单位:
Inhibition of mTOR by a small molecule activator of TSC2
-
批准号:9976416
-
项目类别:
-
资助金额:$24.26万
-
财政年份:2019
-
负责人:Lizbeth K. Hedstrom
-
依托单位:
Inhibitor mediated protein degradation
-
批准号:8451333
-
项目类别:
-
资助金额:$29.35万
-
财政年份:2012
-
负责人:Lizbeth K. Hedstrom
-
依托单位:
Inhibitor mediated protein degradation
-
批准号:8795730
-
项目类别:
-
资助金额:$30.84万
-
财政年份:2012
-
负责人:Lizbeth K. Hedstrom
-
依托单位:
Inhibitor mediated protein degradation
-
批准号:8270782
-
项目类别:
-
资助金额:$30.31万
-
财政年份:2012
-
负责人:Lizbeth K. Hedstrom
-
依托单位:
Inhibitor mediated protein degradation
-
批准号:8607196
-
项目类别:
-
资助金额:$30.74万
-
财政年份:2012
-
负责人:Lizbeth K. Hedstrom
-
依托单位:
IMPDH-targeted antibiotics for select agents
-
批准号:8249803
-
项目类别:
-
资助金额:$105.87万
-
财政年份:2011
-
负责人:Lizbeth K. Hedstrom
-
依托单位:
IMPDH-targeted antibiotics for select agents
-
批准号:8842577
-
项目类别:
-
资助金额:$105.87万
-
财政年份:2011
-
负责人:Lizbeth K. Hedstrom
-
依托单位:
IMPDH-targeted antibiotics for select agents
-
批准号:8655140
-
项目类别:
-
资助金额:$105.87万
-
财政年份:2011
-
负责人:Lizbeth K. Hedstrom
-
依托单位:
IMPDH-targeted antibiotics for select agents
-
批准号:8076480
-
项目类别:
-
资助金额:$111.43万
-
财政年份:2011
-
负责人:Lizbeth K. Hedstrom
-
依托单位:
IMPDH-targeted antibiotics for select agents
-
批准号:8468637
-
项目类别:
-
资助金额:$99.52万
-
财政年份:2011
-
负责人:Lizbeth K. Hedstrom
-
依托单位:
IMP Dehydrogenase
-
批准号:7835359
-
项目类别:
-
资助金额:$27.85万
-
财政年份:2009
-
负责人:Lizbeth K. Hedstrom
-
依托单位:
Enzymes, Coenzyme Metabolic Pathways Gordon Research Conference
-
批准号:7534912
-
项目类别:
-
资助金额:$0.6万
-
财政年份:2008
-
负责人:Lizbeth K. Hedstrom
-
依托单位:
Enzymes, Coenzyme Metabolic Pathways Gordon Research Conference
-
批准号:7651209
-
项目类别:
-
资助金额:$0.4万
-
财政年份:2008
-
负责人:Lizbeth K. Hedstrom
-
依托单位:
Development of IMPDH-Targeted Drugs against Crytosporidium
-
批准号:7324612
-
项目类别:
-
资助金额:$86.11万
-
财政年份:2007
-
负责人:Lizbeth K. Hedstrom
-
依托单位:
Development of IMPDH-Targeted Drugs against Crytosporidium
-
批准号:7659599
-
项目类别:
-
资助金额:$89.5万
-
财政年份:2007
-
负责人:Lizbeth K. Hedstrom
-
依托单位:
海外基金